EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 359 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543 | +54.3% | 24,865 | +34.4% | 0.00% | – |
| Q2 2023 | $352 | +9.3% | 18,501 | +11.5% | 0.00% | – |
| Q1 2023 | $322 | +25.3% | 16,592 | +3.2% | 0.00% | – |
| Q4 2022 | $257 | -99.9% | 16,081 | -3.7% | 0.00% | – |
| Q3 2022 | $261,000 | +12.0% | 16,693 | +48.8% | 0.00% | – |
| Q2 2022 | $233,000 | -97.6% | 11,220 | -97.4% | 0.00% | -100.0% |
| Q1 2022 | $9,732,000 | -81.4% | 429,299 | -85.0% | 0.01% | -80.4% |
| Q4 2021 | $52,389,000 | -11.1% | 2,865,947 | +2.8% | 0.06% | -16.4% |
| Q3 2021 | $58,941,000 | +58.5% | 2,788,195 | +36.6% | 0.07% | +59.5% |
| Q2 2021 | $37,197,000 | -20.5% | 2,041,598 | -1.4% | 0.04% | -26.3% |
| Q1 2021 | $46,761,000 | +59.1% | 2,069,987 | +41.3% | 0.06% | +54.1% |
| Q4 2020 | $29,394,000 | +2.3% | 1,464,606 | +24.7% | 0.04% | -7.5% |
| Q3 2020 | $28,723,000 | +12.5% | 1,174,766 | +9.3% | 0.04% | +2.6% |
| Q2 2020 | $25,527,000 | +376.4% | 1,075,281 | +245.5% | 0.04% | +290.0% |
| Q1 2020 | $5,358,000 | -1.7% | 311,186 | +0.6% | 0.01% | +25.0% |
| Q4 2019 | $5,450,000 | +50.8% | 309,322 | +51.4% | 0.01% | +33.3% |
| Q3 2019 | $3,613,000 | +9.9% | 204,351 | +32.8% | 0.01% | +20.0% |
| Q2 2019 | $3,287,000 | -19.6% | 153,830 | -10.5% | 0.01% | -28.6% |
| Q1 2019 | $4,089,000 | -6.9% | 171,840 | -23.1% | 0.01% | -12.5% |
| Q4 2018 | $4,394,000 | +0.8% | 223,435 | -9.1% | 0.01% | +14.3% |
| Q3 2018 | $4,357,000 | -12.8% | 245,915 | +5.9% | 0.01% | -22.2% |
| Q2 2018 | $4,995,000 | +97.7% | 232,120 | -28.3% | 0.01% | +80.0% |
| Q2 2016 | $2,527,000 | -76.3% | 323,687 | -87.9% | 0.01% | -78.3% |
| Q1 2016 | $10,663,000 | +61.1% | 2,665,849 | +127.1% | 0.02% | +53.3% |
| Q4 2015 | $6,619,000 | +181.8% | 1,173,742 | +180.3% | 0.02% | +150.0% |
| Q3 2015 | $2,349,000 | -58.8% | 418,802 | -72.4% | 0.01% | -50.0% |
| Q2 2015 | $5,701,000 | +634.7% | 1,516,399 | +401.9% | 0.01% | +500.0% |
| Q1 2015 | $776,000 | +84.8% | 302,158 | +3.6% | 0.00% | +100.0% |
| Q4 2014 | $420,000 | -5.8% | 291,694 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $446,000 | -59.6% | 291,694 | -10.5% | 0.00% | -50.0% |
| Q2 2014 | $1,104,000 | -4.2% | 325,857 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $1,153,000 | -2.5% | 325,857 | +68.8% | 0.00% | 0.0% |
| Q4 2013 | $1,183,000 | -20.5% | 193,021 | -24.6% | 0.00% | -25.0% |
| Q3 2013 | $1,488,000 | +169.1% | 255,831 | +110.0% | 0.00% | +300.0% |
| Q2 2013 | $553,000 | – | 121,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |